Home/ Supplements/ Vitamin K/ BP-One

BP-One

product on market Tablet or Pill Patient One 1 MediNutritionals Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 75% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Vitamin K-2, folate, and B12 are researched for their roles in cardiovascular health and homocysteine regulation, though evidence for this specific blend is limited. These nutrients generally support vascular function and metabolic processes. The formulation maintains a high safety profile for most users.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for BP-One
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
75%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

30 mcg (38% DV)
Within RDA (0.2× RDA) 275 studies (A:9, B:175)
800 mcg (200% DV)
2.0× RDA — within safe limits 226 studies (A:10, B:105)
250 mcg (4167% DV)
104.2× RDA — above typical dose 139 studies (A:1, B:44)
Proprietary Blend
1435 mg

Other Ingredients

Dicalcium Phosphate Stearic Acid L-Leucine Croscarmellose Sodium Silicon Dioxide Aqueous Film coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Take 2 tablets once daily as a dietary supplement, or as directed by a health professional.

Warnings & Precautions

Contains: Milk and trace amounts of non-GMO soy

Caution: If pregnant, nursing, or taking any medications, consult doctor before use.

Discontinue use and consult if any adverse reactions occur.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

Formulation Notes

Contains: Milk and trace amounts of non-GMO soy

Free of: Egg, fish, peanuts, crustacean shellfish (lobster, crab, shrimp), tree nuts, wheat, yeast, gluten, corn, sugar, and artificial sweeteners, flavors, colors, and preservatives. Free of ingredients derived from genetically modified organisms (GMOs).

Gluten free

Vegetarian

Additional Information

Helps maintain blood pressure already within normal range

Non GMO

Store in a cool, dry place and avoid excessive heat.

To refill please contact your practitioner or call 1-877-723-0777 or visit www.patientoneformulas.com

BPA free

Metadata

Product Details

UPC / SKU8 53959 00434 2
DSLD Entry Date2019-08-23
Product TypeOther Combinations
FormTablet or Pill
BrandPatient One 1 MediNutritionals
DSLD ID205568
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K 100 mcg
Vitamin World · Tablet or Pill
100
Vitamin K2
Higher Nature · Tablet or Pill
100
Vitamin K-1
The Vitamin Shoppe · Tablet or Pill
100
Vitamin K1 100 mcg
The Vitamin Shoppe · Tablet or Pill
100
Vitamin K1 100 mcg
Country Life · Tablet or Pill
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Patient One 1 MediNutritionals View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.